Kang, Hyerim | Yulchon LLC

Kang, Hyerim

Partner

T. +82-2-528-5217

hrkang@yulchon.com V-card

Practice Areas

Corporate & Finance Mergers & Acquisitions Fund/PE Health Care/Pharmaceuticals

Introduction
Representative Matters
Awards/Recognition
News/Publications

Introduction

Hyerim Kang is a partner at Yulchon LLC who practices primarily in the areas of corporate legal affairs and finance. Ms. Kang graduated from the Seoul National University (SNU) College of Law (LL.B.), and subsequently from the SNU School of Law (LL.M.). After beginning her career as an attorney with Yulchon, Ms. Kang further refined her expertise at Yoon & Yang LLC and rejoined Yulchon in 2024. Ms. Kang has extensive experience in advising corporate clients in various industries including medical and pharmaceutical, finance and manufacturing on corporate legal and finance matters. Ms. Kang is also active in advising clients on cross-border M&As, including Korean companies attracting overseas investment and investing in overseas companies.

Education

2017 Visiting Scholar, University of California, Berkeley (UC Berkeley) School of Law
2012 Seoul National University School of Law, LL.M.
2008 Seoul National University, LL.B.

Experience

2024-present Yulchon LLC
2014-2024 Yoon & Yang LLC
2012-2014 Yulchon LLC

Qualifications

2012 Admitted to Bar , Republic of Korea

Languages

Korean, English

Representative Matters

[Stock Transactions (Acquisitions/Sales)]
Advised Company S, a Japanese biopharmaceutical company, on the acquisition of Korea-Japan operations of Company I, a Swiss biopharmaceutical company
Advised Investment Fund D on its acquisition of shares in Company C, an investment firm, from Company M, a private equity firm
Advised Company S, a telecommunication company, on its acquisition of shares in Company K, a software provider
Advised Holding Company H on its sale of Airline Company J to Airline Company K
Advised Airline Company K on its acquisition of Airline Company A
Advised Company S, an electrical and electronics maker, on its acquisition of Company S, a metal company
Advised Company S, a transportation and warehousing company, on its acquisition of Company V, a U.S. retailer
Advised Private Equity Firm P on its sale of Company T, a pediatric fitness company
Advised Company S, a production studio, on its acquisition of shares in Company M, a movie production company

Advised Company S, a transportation and warehousing company, on its acquisition of Company S, a trading company
Advised Company C, a media company, on its sale of shares in Company B, a drama production company
Advised Private Equity Firm P and Company R, an asset management company, on the sale of their shares in Company M, a medical equipment manufacturer
Advised Company C, a Singaporean medical service company, on its acquisition of Company S, a Singaporean medical service provider
Advised Private Equity Firm P on it sale of Company I, an e-commerce company
Advised Company P, a chemical manufacturing company, on its sale of Company H, a chemical manufacturing company
Advised Company C, an investment firm, on its sale of IT Service Company F to Company D, a service provider
[Investments and Investment Attractions]
Advised Airline Company K on its purchase of perpetual convertible bonds of Airline Company A
Advised Airline Company K on its subion for new shares of Company H, a real estate development firm
Advised Company D, a health food manufacturer, on its investment in Company M, a research and development firm
Advised Company D, a health food manufacturer, on its investment in Company R, a health and medical data science company
Advised Company D, a health food manufacturer, on its investment in Company B, a plant-based meat producing company
Advised Company D, a health food manufacturer, on its investment in Company G, a platform provider
Advised Company S, a telecommunication company, and Holding Company S on their investment in Company H, a gaming software manufacturer
Advised Company M, a pharmaceutical company, on its investment in Company P, an Israeli pharmaceutical company
Advised Holding Company H on its issuance of new shares and exchangeable bonds to Bank K
Advised Company N, an investment firm, on its acquisition of new shares and convertible bonds of Company M, a research and development firm
Advised Holding Company H on its issuance of bonds with warrants through a general public offering
Advised Company S, a private equity firm, and Investment Firm M on their investment in Company W, a content platform company
Advised Retailer I on its attraction of investment from Company Z, a Chinese retailer
[Business/Asset Transfers, Mergers/Splits, and Other Deals]
Advised Company D, a food and beverage company, on its establishment of a joint venture with Company S, a chemical manufacturer, and Trading Company L
Advised Company S, an energy company, on its establishment of a joint venture with Company P, a U.S. energy company
Advised Company K, an airline company, on its funds procurement transactions
Advised Company D, a pharmaceutical manufacturer, on its establishment of a joint venture with Company A, a British biotech company
Advised Company H, a construction company, on the pre-sale of an R&D facility of IT Firm H prior to completion of construction
Advised Company N, a security company, on its business transfer transaction with Company J, a security company
Advised Holding Company D on its merger of Company P, an energy company
Advised Company C, a healthcare provider, on a spin-off transaction

Awards/Recognition

2023 Rising Star, Corporate/M&A, Legal Times
2021-2023 Leading Lawyer, Corporate/M&A, Legal Times

News/Publications

2026. 04. 10. Seminar Yulchon Co-Hosts KGCCI WIR Networking Event on Leadership and Kindness 2026. 04. 10.

2024. 04. 01. Recruitment Yulchon Secures Top Talent with Four M&A Partners Joining from Yoon & Yang 2024. 04. 01.

법무법인(유한) 율촌 | Yulchon LLC

Introduction

Representative Matters

Awards/Recognition

News/Publications